| 1 |
滕晓蕾，谢 云，谢 晖，等. ICU收治重症肺炎的预后风险因素分析[J/CD]. 中华肺部疾病杂志(电子版), 2018, 11(3): 44-48.
|
| 2 |
Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis[J]. J Thromb Haemost, 2020, 18(7): 1738-1742.
|
| 3 |
Ramalingam MB, Huang Y, Lim PAC. Rehabilitation of a post-intensive care unit patient after severe COVID-19 pneumonia[J]. Am J Phys Med Rehabil, 2020, 99(12): 1092-1095.
|
| 4 |
Imran MM, Ahmad U, Usman U, et al. Neutrophil/lymphocyte ratio-a marker of COVID-19 pneumonia severity[J]. Int J Clin Pract, 2020, 21(8): 73-79.
|
| 5 |
Gautam S, Cohen AJ, Stahl Y, et al. Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia[J]. Thorax, 2020, 75(11): 974-981.
|
| 6 |
中国医师协会急诊医师分会. 中国急诊SP临床实践专家共识[J]. 中国急救医学，2016, 36(2): 97-107.
|
| 7 |
Gilani MT, Razavi M, Azad AM. A comparison of simplified acute physiology score ii, acute physiology and chronic health evaluation ii and acute physiology and chronic health evaluation iii scoring system in predicting mortality and length of stay at surgical intensive care unit[J]. Niger Med J, 2014, 55(2): 144-147.
|
| 8 |
Heppner HJ, Sehlhoff B, Niklaus D, et al. Pneumonia Severity Index (PSI), CURB-65, and mortality in hospitalized elderly patients with aspiration pneumonia[J]. Z Gerontol Geriatr, 2011, 44(4): 229-234.
|
| 9 |
申 艳，姜纯国，赵 磊. 支气管肺泡灌洗治疗老年重症肺炎的临床疗效及对炎症因子的影响[J/CD]. 中华肺部疾病杂志(电子版), 2018, 11(2): 150-153.
|
| 10 |
Jain V, Yuan JM. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis[J]. Int J Public Health, 2020, 65(5): 533-546.
|
| 11 |
Torres A, Chalmers JD, Dela Cruz CS, et al. Challenges in severe community-acquired pneumonia: a point-of-view review[J]. Intensive Care Med, 2019, 45(2): 159-171.
|
| 12 |
Lanks CW, Musani AI, Hsia DW. Community-acquired pneumonia and hospital-acquired pneumonia[J]. Med Clin North Am, 2019, 103(3): 487-501.
|
| 13 |
Garnacho-Montero J, Barrero-García I, Gómez-Prieto MG, et al. Severe community-acquired pneumonia: current management and future therapeutic alternatives[J]. Expert Rev Anti Infect Ther, 2018, 16(9): 667-677.
|
| 14 |
梁 欢，高 烨，苗常青，等. 中性粒细胞/淋巴细胞比值对重症肺炎患者28 d死亡风险的预测价值[J]. 中华危重病急救医学，2019, 31(7): 827-831.
|
| 15 |
饶 平. 重症肺炎患者降钙素原、C反应蛋白、外周血白细胞计数及前清蛋白的表达及意义[J]. 海南医学院学报，2018, 206(7): 9-11.
|
| 16 |
Ye W, Chen G, Li X, et al. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19[J]. Respir Res, 2020, 21(1): 169.
|
| 17 |
Wang L, Song Y. Efficacy of zinc given as an adjunct to the treatment of severe pneumonia: A meta-analysis of randomized, double-blind and placebo-controlled trials[J]. Clin Respir J, 2018, 12(3): 857-864.
|
| 18 |
Wongsurakiat P, Chitwarakorn N. Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection[J]. BMC Pulm Med, 2019, 9(1): 179.
|
| 19 |
陈晓珊. 血清PCT, RAGE, sTREM-1表达水平与重症肺炎患者病情严重程度及预后的关系[J]. 标记免疫分析与临床，2020, 27(1): 136-141.
|
| 20 |
Ferrer M, Travierso C, Cilloniz C, et al. Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients[J]. PLoS One, 2018, 13(1): 721-725.
|
| 21 |
Che-Morales JL, Cortes-Telles A. Neutrophil-to-lymphocyte ratio as a serum biomarker associated with community acquired pneumonia[J]. Rev Med Inst Mex Seguro Soc, 2019, 56(6): 537-543.
|
| 22 |
李 萌，姚 莉，王 菁，等. NLR PLR在评估重症肺炎患者预后中的价值[J]. 安徽医学，2020, 41(4): 106-109.
|
| 23 |
Adachi H, Derevnina L, Kamoun S. NLR singletons, pairs, and networks: evolution, assembly, and regulation of the intracellular immunoreceptor circuitry of plants[J]. Curr Opin Plant Biol, 2019, 50(18): 121-131.
|
| 24 |
Wang J, Chai J. Molecular actions of NLR immune receptors in plants and animals[J]. Sci China Life Sci, 2020, 63(9): 1303-1316.
|
| 25 |
Lippi G, Salvagno GL, Gelati M, et al. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays[J]. Clin Chem Lab Med, 2019, 58(1): 77-84.
|
| 26 |
罗 红，王 俐，李毓林. CRP、PCT在新生儿细菌感染性黄疸早期诊断中的应用价值[J]. 中国实验诊断学，2018, 2(7): 1231-1234.
|
| 27 |
Sui YD, Xin WN, Feng LL. Comparison of the clinical application values of PCT, hs-CRP and SAA detection in the early diagnosis of sepsis[J]. Pak J Med Sci, 2020, 36(7): 1683-1687.
|
| 28 |
Liu HH, Wang JS, Lin JZ, et al. LPS induced PCT production via TLR-4/NF-кB passway: it is the difference of G-/G+ bacteremia rats [J]. Cytokine, 2021, 137(23): 317-325.
|
| 29 |
李 莉，温小凤，柯 柳，等. 血清PCT，CRP与APACHEⅡ评分联合检测对ICU老年重症感染的临床意义[J]. 检验医学与临床，2018, 15(10): 116-118.
|
| 30 |
Branche A, Neeser O, Mueller B, et al. Procalcitonin to guide antibiotic decision making[J]. Curr Opin Infect Dis, 2019, 32(2): 130-135.
|